ARQT Historical PE Ratio image   This ARQT PE ratio history page last updated 8/8/2022
ARQT Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2022
8/4/2022
24.61-1.31-5.24NA
Q1 2022
5/5/2022
21.02-1.27-5.08NA
Q4 2021
2/22/2022
16.01-1.42-5.68NA
Q3 2021
11/4/2021
21.56-1.14-4.56NA
Q2 2021
8/5/2021
21.83-0.84-3.36NA
Q1 2021
5/4/2021
33.23-0.76-3.04NA
Q4 2020
2/16/2021
33.69-0.79-3.16NA
Q3 2020
11/5/2020
18.66-1.01-4.04NA
Q2 2020
8/11/2020
24.66-0.94-3.76NA
Q1 2020
5/12/2020
24.70-1.15-4.60NA
ARQT PE History Chart
PeriodPriceGAAPTTMPE
Q2 2022
8/4/2022
24.61-1.31-5.14NA
Q1 2022
5/5/2022
21.02-1.27-4.67NA
Q4 2021
2/22/2022
16.01-1.42-4.16NA
Q3 2021
11/4/2021
21.56-1.14-3.53NA
Q2 2021
8/5/2021
21.83-0.84-3.40NA
Q1 2021
5/4/2021
33.23-0.76-3.50NA
Q4 2020
2/16/2021
33.69-0.79-3.89NA
Q3 2020
11/5/2020
18.66-1.01NANA
Q2 2020
8/11/2020
24.66-0.94NANA
Q1 2020
5/12/2020
24.70-1.15NANA
Quotes delayed 20 minutes

Email EnvelopeFree ARQT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Arcutis Biotherapeutics (ARQT) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ARTL PE Ratio History
ARVN PE Ratio History
ARWR PE Ratio History
ASMB PE Ratio History
ASRT PE Ratio History
ATEC PE Ratio History
ATHA PE Ratio History
ATHX PE Ratio History
ATNF PE Ratio History
ATNX PE Ratio History
How should the ARQT historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Arcutis Biotherapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this ARQT Historical PE Ratio page.

What is the average historical PE for ARQT based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The ARQT historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for ARQT based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The ARQT historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the ARQT Historical PE Ratio information for Arcutis Biotherapeutics' stock. The average ARQT historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ARQT historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ARQT historical PE result, against the recent PE: when this page was posted on 8/5/2022, the most recent closing price for ARQT had been 25.15, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on ARQT or any other given stock, valuation analysis for ARQT can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Arcutis Biotherapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ARQT. Thanks for visiting, and the next time you need to research ARQT Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: AGEM Videos, Top Ten Hedge Funds Holding KFRC, RDBX Average Annual Return.

 

ARQT Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.